On Line Home Study Programs

Overactive Bladder Syndrome(OAB):
Recognizing Symptoms and Recommending Treatment


Program Overview

This program has been developed to provide and opportunity to learn about the recent advances in the treatment of overactive bladder.

Presentation

The program can be completed by viewing the PowerPoint® slide show (using Microsoft® PowerPoint® 97 or later), answering the post-test questions and completing the program evaluation on line. Statements of credit can be printed after successful completion of the program.

Program Information
  • Target Audience

    All Registered Pharmacists.
    This program is not accredited for Pharmacy Technicians.

  • Learning Objectives

    After participating in this program, the pharmacist should be able to:

    • Recognize signs and symptoms that characterize OAB
    • Compare and contrast therapy for OAB with respect to efficacy, safety and cost.
    • Describe contraindications and common adverse effects of OAB therapies.
    • Given a patient case, recommend appropriate treatment options
Program Faculty
  • Faculty Disclosure Statement

    In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, Northeastern University Bouvé College of Health Sciences School of Pharmacy requires that faculty members disclose any relationship (e.g., shareholder, recipient of research grant, consultant, or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on faculty presentations.

  • Faculty and Disclosure Information

    Jennifer Kirwin, PharmD, BCPS
    Assistant Clinical Specialist
    Northeastern University
    Bouvé College of Health Sciences
    School of Pharmacy
    Clinical Pharmacist
    Brigham Internal Medicine Associates Clinic
    Brigham and Women's Hospital

    • Has no actual or potential conflict in relation to this program.
    • Does not plan to discuss unlabeled/investigational uses of a commercial product.

Program Support

This program is supported by an educational grant from GlaxoSmithKline

There is no fee for this program.

Continuing Education Accreditation Information

Northeastern University Bouvé College of Health Sciences School of Pharmacy is approved by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Pharmacists successfully participating in this program will receive a statement of credit for one contact hour (0.1 CEU). Statements of Credit may be printed on-line after successful completion of the learning assessment (70%).

ACPE #027-000-05-109-H01. Initial release date November 10, 2005. Expires November 10, 2008.


Further Disclosure of Unlabeled Use and Disclaimer




SPCS Homepage | ACE Homepage | Site Map
For more information, contact Anita Young, M.Ed., R.Ph. at 617.373.5418